Source link : https://www.newshealth.biz/health-news/esketamine-also-effective-without-adjunctive-antidepressant/
Esketamine nasal spray (Spravato) monotherapy was helpful in improving symptoms of treatment-resistant depression, a randomized, double-blind trial found. Among 379 participants in the efficacy analysis, those who received one of two strengths of esketamine had a significantly greater improvement in average Montgomery-Åsberg Depression Rating Scale (MADRS) total score compared with placebo by day 28, with […]
Author : News Health
Publish date : 2024-11-04 20:50:45
Copyright for syndicated content belongs to the linked Source.